Cellebrite DI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	455.9	401.2	325.11	270.65	246.25	194.91
Revenue Growth (YoY)	18.37%	23.41%	20.12%	9.91%	26.34%	13.42%
Cost of Revenue	73.11	62.59	53.23	50.75	42.56	37.88
Gross Profit	382.8	338.61	271.88	219.91	203.69	157.03
Selling, General & Admin	211.79	183.29	154.26	138.24	124.33	91.59
Research & Development	109.61	98.42	84.39	80.62	65.54	54.38
Operating Expenses	321.4	281.7	238.64	218.86	189.87	145.97
Operating Income	61.4	56.91	33.24	1.04	13.82	11.07
Interest & Investment Income	374.01	18.22	10.57	2.03	0.85	2.71
Currency Exchange Gain (Loss)	-1.35	-1.35	0.21	0.85	-0.19	-0.45
Other Non Operating Income (Expenses)	-349.76	-349.76	-119.58	116.85	67.83	-0.09
EBT Excluding Unusual Items	84.3	-275.98	-75.56	120.76	82.31	13.25
Merger & Restructuring Charges	0	-	-	-	-	-1.85
Pretax Income	84.3	-275.98	-75.56	120.76	82.31	11.4
Income Tax Expense	7.97	7.02	5.54	-0.05	10.91	5.62
Net Income	76.33	-283.01	-81.1	120.81	71.4	5.78
Preferred Dividends & Other Adjustments	-	-	-	4.69	0.96	15.13
Net Income to Common	76.33	-283.01	-81.1	116.11	70.43	-9.34
Net Income Growth	-	-	-	69.20%	1135.01%	-
Shares Outstanding (Basic)	239	209	190	183	144	124
Shares Outstanding (Diluted)	245	209	190	195	162	124
Shares Change (YoY)	22.84%	10.16%	-2.68%	20.96%	30.59%	1.76%
EPS (Basic)	0.32	-1.35	-0.43	0.64	0.49	-0.08
EPS (Diluted)	0.31	-1.35	-0.43	0.59	0.44	-0.08
EPS Growth	-	-	-	34.09%	-	-
Free Cash Flow	140.25	123.61	96.83	13.68	30.94	60.33
Free Cash Flow Per Share	0.57	0.59	0.51	0.07	0.19	0.49
Gross Margin	83.96%	84.40%	83.63%	81.25%	82.72%	80.57%
Operating Margin	13.47%	14.18%	10.22%	0.39%	5.61%	5.68%
Profit Margin	16.74%	-70.54%	-24.95%	42.90%	28.60%	-4.79%
Free Cash Flow Margin	30.76%	30.81%	29.78%	5.05%	12.57%	30.95%
EBITDA	72.06	67.51	43.25	10.24	20.9	16.95
EBITDA Margin	15.80%	16.83%	13.30%	3.78%	8.49%	8.69%
D&A For EBITDA	10.66	10.61	10.01	9.19	7.07	5.88
EBIT	61.4	56.91	33.24	1.04	13.82	11.07
EBIT Margin	13.47%	14.18%	10.22%	0.39%	5.61%	5.68%
Effective Tax Rate	9.45%	-	-	-	13.25%	49.28%
Revenue as Reported	455.9	401.2	325.11	270.65	246.25	194.91

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q